What is PAN?
Discussion Vasculitis is an inflammation of the blood vessels. Often, the term implies the arterial vessels, but venous and capillary vessels can be affected. The nomenclature to describe vasculitis and its classification have varied over time. Arterial vessel size is one method and some more common entities include: Small vessel, mainly Granulomatous – granulomatosis with polyangiitis (aka Wegener’s granulomatosis), eosinophilic granulomatosis with polyangiitis (aka Churg Strauss syndrome) Nongranulomatous – Henoch-Schonlein purpura (HSP), microscopic polyangiitis Medium vessel, mainly Childhood sys...
Source: PediatricEducation.org - February 27, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Consumer Health: What do you know about these 3 rare rheumatic diseases?
September is Rheumatic Disease Awareness Month, which makes this a good time to learn about three rare rheumatic diseases: Behcet's disease, Churg-Strauss syndrome and Takayasu's arteritis. Behcet's disease Behcet's disease, also called Behcet's syndrome, is a rare disorder that causes blood vessel inflammation throughout your body. The disease may be an autoimmune disorder, which means the body's immune system mistakenly attacks some of its own healthy cells. It's likely that genetic and environmental factors play a… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 14, 2022 Category: Databases & Libraries Source Type: news

What Are the Symptoms of Churg-Strauss Syndrome
What Are the Signs and Symptoms of Churg-Strauss Syndrome? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 17, 2020 Category: General Medicine Source Type: news

She collapsed on a flight to the Cleveland Clinic. A doctor from there happened to be on board.
Minutes into her flight to Cleveland for a visit to the renowned Cleveland Clinic, where she  hoped to find answers about her struggle with a rare autoimmune disease, Ashley Spencer  collapsed outside an airplane bathroom. Spencer, from the Philadelphia area, reportedly suffers from Churg-Strauss syndrome, also known as eosinophilic granulomatosis with polyangiitis, a disorder that causes inflammation in the blood vessels, slowing down blood flow to vital […]Related:‘I saved them because I’m a superhero!’: 4-year-old donates bone marrow to his baby brothersA cockroach crawled into a Florida womanâ...
Source: Washington Post: To Your Health - May 7, 2018 Category: Consumer Health News Source Type: news

FDA OKs Drug for Eosinophilic Granulomatosis With Polyangiitis FDA OKs Drug for Eosinophilic Granulomatosis With Polyangiitis
Mepolizumab is the first targeted drug for the rare eosinophil-driven disease formerly known as Churg-Strauss syndrome.FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 13, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

FDA Approves Nucala (mepolizumab) for Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
December 12, 2017 -- The U.S. Food and Drug Administration today expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 12, 2017 Category: Drugs & Pharmacology Source Type: news

FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
FDA approves first drug for a rare autoimmune disease that causes an inflammation in the wall of blood vessels of the body. This is a new indication for a previously-approved drug. (Source: Food and Drug Administration)
Source: Food and Drug Administration - December 12, 2017 Category: American Health Source Type: news

FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
SILVER SPRING, Md., Dec. 12, 2017 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration today expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA),... Biopharmaceuticals, FDA GlaxoSmithKline, Nucala, mepolizumab, eosinophilic granulomatosis, Churg-Strauss (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 12, 2017 Category: Pharmaceuticals Source Type: news

Mepolizumab helps patients with refractory Churg-Strauss syndrome
Mepolizumab, an anti-IL5 monoclonal antibody, increased remission rates, cut exacerbations in half and reduced the need for ongoing corticosteroid therapy in patients with refractory cases of the rare autoimmune disease Churg-Strauss Syndrome, according to research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 17, 2017 Category: Science Source Type: news

Churg-Strauss Syndrome
Title: Churg-Strauss SyndromeCategory: Diseases and ConditionsCreated: 12/7/1998 12:00:00 AMLast Editorial Review: 9/15/2016 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - September 15, 2016 Category: Respiratory Medicine Source Type: news

GSK begins Phase lll study in patients with eosinophilic granulomatosis with polyangiitis
GlaxoSmithKline (GSK) has initiated a Phase III trial of an investigational IL-5 antagonist mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome. (Source: Drug Development Technology)
Source: Drug Development Technology - February 17, 2014 Category: Pharmaceuticals Source Type: news

Churg-Strauss Syndrome
Title: Churg-Strauss SyndromeCategory: Diseases and ConditionsCreated: 12/7/1998 6:32:00 PMLast Editorial Review: 1/15/2014 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - January 15, 2014 Category: Respiratory Medicine Source Type: news

Colin Murray obituary
My father, Colin Murray, who has died aged 65 of heart failure after suffering from the autoimmune disorder Churg-Strauss syndrome, was a distinguished anthropologist whose scholarship and lifelong friendships were characterised by a deep humanity.Edinburgh-born, he undertook a stint of VSO teaching in a bush school in Uganda before going to university. This experience led him to change from studying classics to social anthropology at Fitzwilliam College, Cambridge, and thence to several years of postgraduate fieldwork in a Lesotho village. Here the Pitse inhabitants became an extended family and these early trips to Afric...
Source: Guardian Unlimited Science - December 22, 2013 Category: Science Tags: theguardian.com Obituaries Lesotho Anthropology Scotland Africa Science Source Type: news